Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
625 दिनों पहले
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
891 दिनों पहले
Sensex, Nifty Subdued In Early Trade
Indian shares were subdued on Thursday amid rising tensions between India and Pakistan and concerns about the outlook for the global economy.
RTTNews
|
46 मिनटों पहले
Australian Market Swings To Slight Gains In Mid-market
The Australian market is turning its early losses to slight gains in mid-market moves on Thursday after opening in the red, extending the gains in the previous session, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying just below the 8,200 level, with gains in gold miners and technology stocks partially offset by weakness in financial stocks.
RTTNews
|
1घंटे 34 मिनट पहले
Asian Markets Track Wall Street Higher
Asian stock markets are trading mostly higher on Thursday, following the broadly positive cues from Wall Street overnight, amid optimism surrounding the upcoming U.S.-China trade talks to take place in Switzerland this week and China's new stimulus measures. Meanwhile, the US Fed left interest rates unchanged, and also warned of increasing risks of higher unemployment and higher inflation.
RTTNews
|
1घंटे 57 मिनट पहले
Sensex, Nifty Likely To Open On Cautious Note
Indian shares look set to open on a cautious note Thursday as Pakistan troops continue to resort to cross-border shelling along the Line of Control (LoC) in Kupwara district of Jammu and Kashmir for the second consecutive day.
RTTNews
|
2घंटे 28 मिनट पहले
Japanese Market Modestly Lower
The Japanese market is trading modestly lower on Thursday, extending the losses in the previous session, despite the broadly positive cues from Wall Street overnight. The Nikkei 225 is falling well below the 36,700 level, with weakness in index heavyweights, exporters and financial stocks partially offset by gains in technology stocks.
RTTNews
|
3घंटे 19 मिनट पहले
Australian Market Slightly Lower
The Australian market is trading slightly lower on Thursday, giving up some of the slight gains in the previous session, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying well below the 8,200 level, with weakness in iron ore miners and financial stocks partially offset by gains in gold miners and technology stocks.
RTTNews
|
3घंटे 56 मिनट पहले
